Overall, these findings strongly support the ANXA1 value as a predictive and prognostic biomarker in CRC and RC, given its association with nCRT poor response, advanced disease stages, and aggressive tumor features, with some specific functional correlations for each location. Here, ANXA1 is linked to colorectal carcinoma.